Filtered By:
Condition: Diabetes
Management: Health Insurance

This page shows you your search results in order of date.

Order by Relevance | Date

Total 48 results found since Jan 2013.

Association between COVID-19 and incidence of cardiovascular disease and all-cause mortality among patients with diabetes
ConclusionsThis study showed that patients with diabetes hospitalized due to COVID-19 had an increased risk of CVD, coronary heart disease, stroke incidence, and mortality than those who were not COVID-19 infected, suggesting more careful prevention and management among patients with COVID-19.
Source: Frontiers in Endocrinology - July 27, 2023 Category: Endocrinology Source Type: research

Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Are Associated With Reduced Risk of SARS-CoV-2 Infection Without Comorbidities Including Diabetes, Hypertension, and Dyslipidemia: A Propensity Score-Matched Nationwide Cohort Study
CONCLUSION: H2RA and PPI use is associated with a decreased risk for SARS-CoV-2 infection but does not affect clinical outcome. Comorbidities including diabetes, hypertension, and dyslipidemia seem to offset the protective effect of H2RA and PPI.PMID:37012686 | PMC:PMC10070049 | DOI:10.3346/jkms.2023.38.e99
Source: J Korean Med Sci - April 4, 2023 Category: General Medicine Authors: Bokyung Kim Jin-Hyung Jung Kyungdo Han Seungkyung Kang Eunwoo Lee Hyunsoo Chung Sang Gyun Kim Soo-Jeong Cho Source Type: research

Incidence of newly diagnosed diabetes after Covid-19
Conclusions/interpretationCovid-19 confers an increased risk for type 2 diabetes. If confirmed, these results support the active monitoring of glucose dysregulation after recovery from mild forms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.Graphical abstract
Source: Diabetologia - May 8, 2022 Category: Endocrinology Source Type: research

The New $10 Billion COVID-19 Deal Leaves Uninsured People at Risk
When Senators announced on Monday that they reached a deal for $10 billion in additional funding for the coronavirus response, many public health experts were dismayed that the package will not include aid for vaccines abroad. But another area that is likely to get shorted is the program that has covered the costs of coronavirus tests, treatments and vaccines for uninsured Americans. That lack of funding could not only hurt the most vulnerable Americans, experts say, but also fuel future outbreaks of COVID-19. The program for uninsured people began winding down late last month. The Biden Administration repeatedly asked la...
Source: TIME: Health - April 5, 2022 Category: Consumer Health News Authors: Abigail Abrams Tags: Uncategorized COVID-19 Source Type: news